Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

Researchers developed a DNA barcoding assay to measure nanoparticle cargo escape in living organisms, enabling a new class of lipid nanoparticles for more efficient gene editing.

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

Researchers developed a method to measure how efficiently lipid nanoparticles release genetic cargo within mice, overcoming a longstanding hurdle in gene therapy.

(Nanowerk News) DNA-nanoparticle motors are exactly as they sound: tiny artificial motors that use the structures of DNA and RNA to propel motion by enzymatic RNA degradation. Essentially, chemical ...

LONDON, Nov 5 (Reuters) - Nanoparticles can damage the DNA of cells from a distance, even without crossing the cellular barriers that protect certain parts of the body, British researchers said on ...

DNA-nanoparticle motors are exactly as they sound: tiny artificial motors that use the structures of DNA and RNA to propel motion by enzymatic RNA degradation. Essentially, chemical energy is ...

Researchers from the Institute for Molecular Science aimed to level out the speed difference between artificial motors and motor proteins by improving the nanoscale artificial motor using their ...